Serum brain-derived neurotrophic factor and cognitive functioning in underweight, weight-recovered and partially weight-recovered females with anorexia nervosa

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 54, Issue , 2014, Pages 163-169

  Zwipp, Johannes ^a   Hass, Johanna ^a   Schober, Ilka ^a   Geisler, Daniel ^a   Ritschel, Franziska ^a   Seidel, Maria ^a   Weiss, Jessika ^a   Roessner, Veit ^a   Hellweg, Rainer ^b   Ehrlich, Stefan ^a,c,d  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anorexia nervosa; BDNF; Cognitive functioning; Longitudinal; Weight gain

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADOLESCENT; ADULT; AGED; ANOREXIA NERVOSA; ARTICLE; BODY MASS; BRAIN DERIVED NEUROTROPHIC FACTOR BRAIN LEVEL; BRAIN LEVEL; CHILD; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PSYCHOLOGIC TEST; PSYCHOMOTOR ACTIVITY; UNDERWEIGHT; WEIGHT GAIN; BLOOD; BODY WEIGHT; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

ADOLESCENT; ANOREXIA NERVOSA; BODY MASS INDEX; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; THINNESS; WEIGHT GAIN; YOUNG ADULT;

EID: 84902660005     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.05.006     Document Type: Article

References (71)

1. Barbosa I.G., Rocha N.P., Huguet R.B., Ferreira R.A., Salgado J.V., Carvalho L.A., et al. Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers. J Affect Disord 2012, 137(1-3):151-155. [Mar].
2. Brooks S.J., Nilsson E.K., Jacobsson J.A., Stein D.J., Fredriksson R., Lind L., et al. BDNF polymorphisms are linked to poorer working memory performance, reduced cerebellar and hippocampal volumes and differences in prefrontal cortex in a Swedish elderly population. PLoS One 2014, 9(1):e82707. [Jan 23].
3. Bus B.A.A., Molendijk M.L., Penninx B.J.W.H., Buitelaar J.K., Kenis G., Prickaerts J., et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011, 36(2):228-239. [Feb].
4. Chiaretti A., Piastra M., Polidori G., Di Rocco C., Caresta E., Antonelli A., et al. Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury. Intensive Care Med 2003, 29(8):1329-1338. [Aug].
5. Chourbaji S., Hellweg R., Brandis D., Zörner B., Zacher C., Lang U.E., et al. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 2004, 121(1-2):28-36. [Feb 5].
6. Chung Y.-C., Park C.-H., Kwon H.-K., Park Y.-M., Kim Y.S., Doo J.-K., et al. Improved cognitive performance following supplementation with a mixed-grain diet in high school students: a randomized controlled trial. Nutrition 2012, 28(2):165-172. [Feb].
7. Cunha C., Brambilla R., Thomas K.L. A simple role for BDNF in learning and memory?. Front Mol Neurosci 2010, 3:1.
8. Deuschle M., Gilles M., Scharnholz B., Lederbogen F., Lang U.E., Hellweg R. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment. Pharmacopsychiatry 2013, 46(2):54-58. [Mar].
9. Dias V.V., Brissos S., Frey B.N., Andreazza A.C., Cardoso C., Kapczinski F. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord 2009, 11(6):663-671. [Sep].
10. Driscoll I., Martin B., An Y., Maudsley S., Ferrucci L., Mattson M.P., et al. Plasma BDNF is associated with age-related white matter atrophy but not with cognitive function in older, non-demented adults. PLoS One 2012, 7(4):e35217.
11. Duchesne M., Mattos P., Fontenelle L.F., Veiga H., Rizo L., Appolinario J.C. Neuropsychology of eating disorders: a systematic review of the literature. Rev Bras Psiquiatr 2004, 26(2):107-117. [Jun].
12. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112(2):257-269. [Jan 24].
13. Ehrlich S., Burghardt R., Weiss D., Salbach-Andrae H., Craciun E.M., Goldhahn K., et al. Glial and neuronal damage markers in patients with anorexia nervosa. J Neural Transm 2008, 115(6):921-927. [Jun].
14. Ehrlich S., Salbach-Andrae H., Weiss D., Burghardt R., Goldhahn K., Craciun E.M., et al. S100B in underweight and weight-recovered patients with anorexia nervosa. Psychoneuroendocrinology 2008, 33(6):782-788. [Jul].
15. Ehrlich S., Salbach-Andrae H., Eckart S., Merle J.V., Burghardt R., Pfeiffer E., et al. Serum brain-derived neurotrophic factor and peripheral indicators of the serotonin system in underweight and weight-recovered adolescent girls and women with anorexia nervosa. J Psychiatry Neurosci 2009, 34(4):323-329. [Jul].
16. Fichter M., Quadflieg N. Strukturiertes Inventar für Anorektische und Bulimische Eßtörungen (SIAB). Handanweisung 1999, Hogrefe, Göttingen.
17. Fichter M., Quadflieg N. The structured interview for anorexic and bulimic disorders for DSM-IV and ICD-10 (SIAB-EX): reliability and validity. Eur Psychiatry 2001, 16(1):38-48. [Feb].
18. Frank G.K., Bailer U.F., Henry S., Wagner A., Kaye W.H. Neuroimaging studies in eating disorders. CNS Spectr 2004, 9(7):539-548. [Jul].
19. Franke G. SCL-90-R. Die Symptom-Checkliste von L. R. Derogatis (Deutsche Version) 2002, Hogrefe, Göttingen.
20. Gelegen C., van den Heuvel J., Collier D.A., Campbell I.C., Oppelaar H., Hessel E., et al. Dopaminergic and brain-derived neurotrophic factor signalling in inbred mice exposed to a restricted feeding schedule. Genes Brain Behav 2008, 7(5):552-559. [Jul].
21. Gillberg I.C., Billstedt E., Wentz E., Anckarsäter H., Råstam M., Gillberg C. Attention, executive functions, and mentalizing in anorexia nervosa eighteen years after onset of eating disorder. J Clin Exp Neuropsychol 2010, 32(4):358-365. [Apr].
22. Golden N.H., Ashtari M., Kohn M.R., Patel M., Jacobson M.S., Fletcher A., et al. Reversibility of cerebral ventricular enlargement in anorexia nervosa, demonstrated by quantitative magnetic resonance imaging. J Pediatr 1996, 128(2):296-301. [Feb].
23. Gunston G.D., Burkimsher D., Malan H., Sive A.A. Reversible cerebral shrinkage in kwashiorkor: an MRI study. Arch Dis Child 1992, 67(8):1030-1032. [Aug].
24. Hatch A., Madden S., Kohn M.R., Clarke S., Touyz S., Gordon E., et al. In first presentation adolescent anorexia nervosa, do cognitive markers of underweight status change with weight gain following a refeeding intervention?. Int J Eat Disord 2010, 43(4):295-306. [May].
25. Hebebrand J., Casper R., Treasure J., Schweiger U. The need to revise the diagnostic criteria for anorexia nervosa. J Neural Transm 2004, 111(7):827-840. [Jul].
26. Hentschel F., Schmidbauer M., Detzner U., Blanz B., Schmidt M.H. Reversible changes in brain volume in anorexia nervosa. Z Kinder Jugendpsychiatr 1995, 23(2):104-112. [Jun].
27. Hinney A., Scherag S., Hebebrand J. Genetic findings in anorexia and bulimia nervosa. Prog Mol Biol Transl Sci 2010, 94:241-270.
28. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001, 24:677-736.
29. Jockers-Scherübl M.C., Danker-Hopfe H., Mahlberg R., Selig F., Rentzsch J., Schürer F., et al. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neurosci Lett 2004, 371(1):79-83. [Nov 16].
30. Jung W.H., Jang J.H., Byun M.S., An S.K., Kwon J.S. Structural brain alterations in individuals at ultra-high risk for psychosis: a review of magnetic resonance imaging studies and future directions. J Korean Med Sci 2010, 25(12):1700-1709. [Dec].
31. Kambeitz J.P., Bhattacharyya S., Kambeitz-Ilankovic L.M., Valli I., Collier D.A., McGuire P. Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neurosci Biobehav Rev 2012, 36(9):2165-2177. [Oct].
32. Kapczinski F., Frey B.N., Kauer-Sant'Anna M., Grassi-Oliveira R. Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev Neurother 2008, 8(7):1101-1113. [Jul].
33. Kerem N.C., Katzman D.K. Brain structure and function in adolescents with anorexia nervosa. Adolesc Med 2003, 14(1):109-118. [Feb].
34. Kernie S.G., Liebl D.J., Parada L.F. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 2000, 19(6):1290-1300. [Mar 15].
35. Komulainen P., Pedersen M., Hänninen T., Bruunsgaard H., Lakka T.A., Kivipelto M., et al. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study. Neurobiol Learn Mem 2008, 90(4):596-603. [Nov].
36. Korte M., Griesbeck O., Gravel C., Carroll P., Staiger V., Thoenen H., et al. Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proc Natl Acad Sci 1996, 93(22):12547-12552. [Oct 29].
37. Kromeyer-Hauschild K., Wabitsch D., Kunze F., Gellert H. Perzentile für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001, 149:807-818.
38. Le Grange D., Crosby R.D., Engel S.G., Cao L., Ndungu A., Crow S.J., et al. DSM-IV-defined anorexia nervosa versus subthreshold anorexia nervosa (EDNOS-AN). Eur Eat Disord Rev 2013, 21(1):1-7. [Jan].
39. Lykissas M.G., Batistatou A.K., Charalabopoulos K.A., Beris A.E. The role of neurotrophins in axonal growth, guidance, and regeneration. Curr Neurovasc Res 2007, 4(2):143-151. [May].
40. Lyons W.E., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 1999, 96(26):15239-15244. [Dec 21].
41. Madsen A.L., Karle A., Rubin P., Cortsen M., Andersen H.S., Hemmingsen R. Progressive atrophy of the frontal lobes in first-episode schizophrenia: interaction with clinical course and neuroleptic treatment. Acta Psychiatr Scand 1999, 100(5):367-374. [Nov].
42. Mainz V., Schulte-Rüther M., Fink G.R., Herpertz-Dahlmann B., Konrad K. Structural brain abnormalities in adolescent anorexia nervosa before and after weight recovery and associated hormonal changes. Psychosom Med 2012, 74(6):574-582. [Aug].
43. Miyajima F., Ollier W., Mayes A., Jackson A., Thacker N., Rabbitt P., et al. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes Brain Behav 2008, 7(4):411-417. [Jun].
44. Molendijk M.L., Bus B.A.A., Spinhoven P., Penninx B.W.J.H., Kenis G., Prickaerts J., et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 2011, 16(11):1088-1095. [Nov].
45. Molendijk M.L., Bus B.A.A., Spinhoven P., Kaimatzoglou A., Oude Voshaar R.C., Penninx B.W.J.H., et al. A systematic review and meta-analysis on the association between BDNF val(66)met and hippocampal volume-a genuine effect or a winners curse?. Am J Med Genet B Neuropsychiatr Genet 2012, 159B(6):731-740. [Sep].
46. Molendijk M.L., Haffmans J.P.M., Bus B.A.A., Spinhoven P., Penninx B.W.J.H., Prickaerts J., et al. Serum BDNF concentrations show strong seasonal variation and correlations with the amount of ambient sunlight. PLoS One 2012, 7(11):e48046.
47. Monteleone P., Tortorella A., Martiadis V., Serritella C., Fuschino A., Maj M. Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom Med 2004, 66(5):744-748. [Oct].
48. Monteleone P., Fabrazzo M., Martiadis V., Serritella C., Pannuto M., Maj M. Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: relationships to co-morbid depression, psychopathology and hormonal variables. Psychol Med 2005, 35(6):897-905. [Jun].
49. Nagahara A.H., Tuszynski M.H. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 2011, 10(3):209-219. [Mar].
50. Nakazato M., Hashimoto K., Shimizu E., Kumakiri C., Koizumi H., Okamura N., et al. Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders. Biol Psychiatry 2003, 54(4):485-490. [Aug 15].
51. Nakazato M., Hashimoto K., Yoshimura K., Hashimoto T., Shimizu E., Iyo M. No change between the serum brain-derived neurotrophic factor in female patients with anorexia nervosa before and after partial weight recovery. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30(6):1117-1121. [Aug 30].
52. Nakazato M., Tchanturia K., Schmidt U., Campbell I.C., Treasure J., Collier D.A., et al. Brain-derived neurotrophic factor (BDNF) and set-shifting in currently ill and recovered anorexia nervosa (AN) patients. Psychol Med 2009, 39(6):1029-1035. [Jun].
53. Nakazato M., Hashimoto K., Shimizu E., Niitsu T., Iyo M. Possible involvement of brain-derived neurotrophic factor in eating disorders. IUBMB Life 2012, 64(5):355-361. [May].
54. Neumärker K.J., Bzufka W.M., Dudeck U., Hein J., Neumärker U. Are there specific disabilities of number processing in adolescent patients with Anorexia nervosa? Evidence from clinical and neuropsychological data when compared to morphometric measures from magnetic resonance imaging. Eur Child Adolesc Psychiatry 2000, 9(S2):S111-S121. [Jun].
55. Ohrmann P., Kersting A., Suslow T., Lalee-Mentzel J., Donges U.-S., Fiebich M., et al. Proton magnetic resonance spectroscopy in anorexia nervosa: correlations with cognition. Neuroreport 2004, 15(3):549-553. [Mar 1].
56. Oswald W., Roth E. Der Zahlen-Verbindungs-test (ZVT) 1987, Hogrefe, Göttingen. 2nd ed.
57. Patterson S.L., Abel T., Deuel T.A., Martin K.C., Rose J.C., Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron 1996, 16(6):1137-1145. [Jun].
58. Rathner G., Waldherr K. Eating Disorder Inventory-2. Eine deutschsprachige Validierung mit Normen für weibliche und männliche Jugendliche. Z Klin Psychol Psychiatr Psychother 1997, 157-182.
59. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 2001, 15(10):1748-1757. [Oct 1].
60. Rybakowski J.K., Borkowska A., Skibinska M., Hauser J. Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Mol Psychiatry 2006, 11(2):122-124. [Feb].
61. Sugiyama N., Kanba S., Arita J. Temporal changes in the expression of brain-derived neurotrophic factor mRNA in the ventromedial nucleus of the hypothalamus of the developing rat brain. Brain Res Mol Brain Res 2003, 115(1):69-77. [Jul 4].
62. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T., et al. Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res 2002, 110(3):249-257. [Jul 31].
63. Trajkovska V., Marcussen A.B., Vinberg M., Hartvig P., Aznar S., Knudsen G.M. Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull 2007, 73(1-3):143-149. [Jun 15].
64. Tyler W.J., Alonso M., Bramham C.R., Pozzo-Miller L.D. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem 2002, 9(5):224-237.
65. Vinogradov S., Fisher M., Holland C., Shelly W., Wolkowitz O., Mellon S.H. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia?. Biol Psychiatry 2009, 66(6):549-553. [Sep 15].
66. Waterhouse E.G., Xu B. New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci 2009, 42(2):81-89. [Oct].
67. Xiao J., Wong A.W., Willingham M.M., van den Buuse M., Kilpatrick T.J., Murray S.S. Brain-derived neurotrophic factor promotes central nervous system myelination via a direct effect upon oligodendrocytes. Neurosignals 2010, 18(3):186-202.
68. Xu B., Goulding E.H., Zang K., Cepoi D., Cone R.D., Jones K.R., et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 2003, 6(7):736-742. [Jul].
69. Yamada K., Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J Pharmacol Sci 2003, 91(4):267-270. [Apr].
70. Yasui-Furukori N. Update on the development of lurasidone as a treatment for patients with acute schizophrenia. Drug Des Devel Ther 2012, 6:107-115.
71. Zhang Q., Liu G., Wu Y., Sha H., Zhang P., Jia J. BDNF promotes EGF-induced proliferation and migration of human fetal neural stem/progenitor cells via the PI3K/Akt pathway. Molecules 2011, 16(12):10146-10156.